Betty Peng
- Hepatology top 5%
- Epidemiology
- Infectious Diseases top 10%
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging
- Co-authors
- William E. DelaneyGuofeng ChengTian YangHuiling YangYu MeiRuoyu GongAmoreena C. CorsaNikos Pagratis
- Topics
- Hepatitis C virus research (10 papers)Hepatitis B Virus Studies (6 papers)HIV/AIDS drug development and treatment (5 papers)
- Partner nations
- United StatesItaly
In The Last Decade
Betty Peng
13 papers receiving 284 citations
Peers
Comparison fields: 5 of 26
- Hepatology 268
- Epidemiology 241
- Infectious Diseases 130
- Molecular Biology 38
- Radiology, Nuclear Medicine and Imaging 27
Countries citing papers authored by Betty Peng
This map shows the geographic impact of Betty Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Betty Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Betty Peng more than expected).
Fields of papers citing papers by Betty Peng
This network shows the impact of papers produced by Betty Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Betty Peng. The network helps show where Betty Peng may publish in the future.
Co-authorship network of co-authors of Betty Peng
This figure shows the co-authorship network connecting the top 25 collaborators of Betty Peng. A scholar is included among the top collaborators of Betty Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Betty Peng. Betty Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 50 | |
| 2 | 24 | |
| 3 | 17 | |
| 4 | 23 | |
| 5 | 38 | |
| 6 | 30 | |
| 7 | 34 | |
| 8 | 7 | |
| 9 | 8 | |
| 10 | 4 | |
| 11 | 39 | |
| 12 | GS-9190, a novel substituted imidazo-pyridine analogue, is a potent inhibitor of hepatitis C virus replication in vitro and remains active against known drug-resistant mutants | 8 |
| 13 | Mechanistic characterization of GS-9190, a novel non-nucleoside inhibitor of HCV NS5B polymerase with potent antiviral activity and a unique mechanism of action | 12 |
About Betty Peng
Betty Peng is a scholar working on Hepatology, Infectious Diseases and Virology, having authored 13 papers that have together received 294 indexed citations. Recurring topics across this work include Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (6 papers) and HIV/AIDS drug development and treatment (5 papers). The work is most often cited by research in Hepatology (268 citations), Infectious Diseases (130 citations) and Epidemiology (241 citations). Betty Peng has collaborated with scholars based in United States and Italy. Frequent co-authors include William E. Delaney, Guofeng Cheng, Tian Yang, Huiling Yang, Yu Mei, Ruoyu Gong, Amoreena C. Corsa, Nikos Pagratis, Hongmei Mo and John O. Link. Their work appears in journals such as Gastroenterology, Antimicrobial Agents and Chemotherapy and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.